Family Medicine Doctors in Trafalgar, IN Accepting Medicare
4 Family Medicine doctors found. Showing 1 - 4
 Patricia Ann Hallett, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 106 S State Road 135 Ste C, Trafalgar, IN 46181 Phone: 317-878-4972 Fax: 317-878-4593 |
Mirela Ungureanu, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 14 Trafalgar Sq, Trafalgar, IN 46181 Phone: 317-412-9190 Fax: 317-878-2302 |
 Michael W Chitwood, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 14 Trafalgar Sq, Trafalgar, IN 46181 Phone: 317-412-9190 Fax: 317-878-2302 |
John M Walker, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 106 S State Road 135 Ste C, Trafalgar, IN 46181 Phone: 317-878-4972 |
News Archive
Adamis Pharmaceuticals' Epinephrine injection categorized as a generic
Adamis Pharmaceuticals Corporation announced on July 23 that its wholly owned subsidiary, Adamis Labs launched and shipped the first orders of the company's Epinephrine Injection, USP, 1:1000 (0.3mg prefilled single dose syringe) ("PFS"). Today, Adamis Labs reports that at least two major data base reference companies (Medi-Span® and First DataBank) placed the Company's PFS in their generic category.
Research offers solution to increase organ donations and save lives
Eighteen people die every day waiting for transplants, and a new patient is added to the organ transplant list every 10 minutes. Much of the problem surrounds the lack of registered donors.
Electronic cigarettes pose particular risks to the developing brains, organs of young people
Although heavily promoted as a safer cigarette and an aid to quit smoking, electronic cigarettes and the nicotine they deliver pose particular risks to the developing brains and organs of children. Use of electronic cigarettes by school-age children has surpassed traditional cigarette smoking, and it is critical to recognize and understand the risks related to nicotine exposure, addiction, and the poor regulation of these products, as described in the comprehensive Review article "Electronic Cigarettes: Vulnerability of Youth," published in Pediatric Allergy, Immunology, and Pulmonology, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
Janssen submits Marketing Authorization Application for Ibrutinib
Janssen-Cilag International NV (Janssen) announced today it has submitted a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for ibrutinib for the treatment of adult patients with relapsed or refractory chronic lymphocytic leukemia (CLL)/small lymphocytic leukemia (SLL) or relapsed or refractory mantle cell lymphoma (MCL), two forms of blood cancer.
› Verified 7 days ago